Skip to main content

Advertisement

SpringerLink
Log in

Clinical guidelines

Expert recommendations for NSAID use: a user-friendly model?

  • News & Views
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

Although tens of millions of individuals worldwide use NSAIDs daily, balancing the competing risks and benefits of these agents continues to be a challenge. Evidence-based treatment guidelines and expert opinions have been promulgated, but will they actually translate to improved patient care? A new web-based tool could aid physicians' treatment decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moskowitz, R. W., Abramson, S. B., Berenbaum, F., Simon, L. S. & Hochberg, M. Coxibs and NSAIDs—is the air any clearer? Perspectives from the OARSI/International COX-2 Study Group Workshop 2007. Osteoarthritis Cartilage 15, 849–856 (2007).

    Article  CAS  Google Scholar 

  2. American College of Rheumatology ad hoc group on use of selective and nonselective nonsteroidal antiinflammatory drugs. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper. Arthritis Rheum. 59, 1058–1073 (2008).

  3. Reid, M. C. et al. Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes. Pain Med. 11, 1063–1071 (2010).

    Article  Google Scholar 

  4. Burmester, G. et al. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann. Rheum. Dis. doi:10.1136/ard.2010.128660.

  5. Fitch, K. et al. The RAND/UCLA Appropriateness Method User's Manual (RAND, Santa Monica, 2001).

    Google Scholar 

  6. Ismar Healthcare. Sensar [online], (2010).

  7. Krum, H. et al. Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program. Eur. J. Heart Fail. 11, 542–550 (2009).

    Article  CAS  Google Scholar 

  8. Bombardier, C. et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N. Engl. J. Med. 343, 1520–1528 (2000).

    Article  CAS  Google Scholar 

  9. Farkouh, M. E. et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet 364, 675–684 (2004).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Pathology, NYU Langone Medical Center, 550 First Avenue, New York, 10022, NY, USA

    Steven B. Abramson

Authors
  1. Steven B. Abramson
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

S. B. Abramson has acted as a consultant for NicOx and Pfizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abramson, S. Expert recommendations for NSAID use: a user-friendly model?. Nat Rev Rheumatol 7, 133–134 (2011). https://doi.org/10.1038/nrrheum.2010.230

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2010.230

  • Springer Nature Limited

Search

Navigation